Skip to content

Regenxbio RGNX Market capitalization

Market capitalization at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$81.68B+17.8%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$2.28B-63.1%
Biogen logo
BiogenBIIB
$26.91B+34.3%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$10.86B-19.4%
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
$1.08B+189%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$2.06B-39.4%

Other financials

Income statement

See full
Revenue$6.4M-92.8%
Gross profit$14.9M+35.7%
Operating income-$83.4M-787%
Net income-$90.1M-1,580%
EPS (diluted)-$1.72-1,533%

Balance sheet

See full
Cash & equivalents$15.2M-88.3%
Total debt$71.1M-11.0%
Total equity$21.1M-92.3%
Total assets$341.9M-30.4%

Cash flow

See full
Operating cash flow-$76.2M-327%
CapEx$1.2M+20.6%
Free cash flow-$77.4M-337%

Valuation

See full
Enterprise value$585.22M+56.3%
P/S+3.3×

Profitability

See full
Gross margin59.7%+1.0pp
Operating margin-292.3%-613pp
Net margin-330.2%-588pp
FCF margin-269.2%-364pp

Returns & leverage

See full
Return on equity-196.4%-288pp
Debt / equity3.4×+3.1×
Current ratio2.6×-0.3×

Where this comes from

Computed from the period-end share price: $432.52M.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Regenxbio's market capitalization?
Regenxbio (RGNX) reported market capitalization of $432.52M in Q1 2026.
How has Regenxbio's market capitalization changed year-over-year?
Regenxbio's market capitalization increased by 20.8% year-over-year, from $358.12M to $432.52M.
What is the long-term trend for Regenxbio's market capitalization?
Over 5 years (2020 to 2025), Regenxbio's market capitalization has grown at a -17.8% compound annual growth rate (CAGR), from $1.94B to $728.97M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.